We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFV icon
126
iShares MSCI EAFE Value ETF
EFV
$28.7B
$72.3M 0.16%
1,399,261
+221,423
+19% +$11.4M
IBM icon
127
IBM
IBM
$207B
$71.3M 0.15%
484,523
-31,859
-6% -$4.8M
DD
128
DELISTED
Du Pont De Nemours E I
DD
$69.8M 0.15%
864,454
-31,629
-4% -$2.53M
IVW icon
129
iShares S&P 500 Growth ETF
IVW
$73.8B
$69.4M 0.15%
2,028,440
-39,440
-2% -$1.34M
AEP icon
130
American Electric Power
AEP
$69.4B
$69.4M 0.15%
998,293
+204,069
+26% +$14.2M
RDS.A
131
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$69.1M 0.15%
1,299,772
+123,739
+11% +$6.63M
SLB icon
132
SLB Ltd
SLB
$73.8B
$68.6M 0.15%
1,042,359
+2,630
+0.3% +$188K
VLO icon
133
Valero Energy
VLO
$93.3B
$68.2M 0.15%
1,010,437
+63,056
+7% +$4.09M
GLW icon
134
Corning
GLW
$125B
$67.7M 0.15%
2,251,916
-3,992
-0.2% -$115K
BKNG icon
135
Booking.com
BKNG
$148B
$66.9M 0.14%
894,225
+47,275
+6% +$3.47M
GILD icon
136
Gilead Sciences
GILD
$161B
$65.5M 0.14%
925,719
+27,107
+3% +$1.8M
BMY icon
137
Bristol-Myers Squibb
BMY
$133B
$65.2M 0.14%
1,169,774
-29,788
-2% -$1.62M
NLSN
138
DELISTED
Nielsen Holdings plc
NLSN
$64.2M 0.14%
1,659,890
+840,485
+103% +$33.4M
VWO icon
139
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$63.5M 0.14%
1,554,844
+294,800
+23% +$11.9M
IJK icon
140
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$63.1M 0.14%
1,284,488
+138,892
+12% +$6.75M
SBUX icon
141
Starbucks
SBUX
$121B
$63M 0.14%
1,080,359
+44,084
+4% +$2.67M
BDX icon
142
Becton Dickinson
BDX
$44.9B
$62.6M 0.14%
329,061
+23,233
+8% +$4.24M
GD icon
143
General Dynamics
GD
$103B
$61.7M 0.13%
311,682
+19,925
+7% +$3.9M
VNQ icon
144
Vanguard Real Estate ETF
VNQ
$39.2B
$61.2M 0.13%
735,598
+25,195
+4% +$2.1M
RGC
145
DELISTED
Regal Entertainment Group
RGC
$61.2M 0.13%
2,990,962
+425,196
+17% +$9.02M
TSM icon
146
TSMC
TSM
$2.16T
$60.7M 0.13%
1,735,668
-26,080
-1% -$902K
HAL icon
147
Halliburton
HAL
$26.8B
$60.7M 0.13%
1,420,313
+81,701
+6% +$3.75M
NEE icon
148
NextEra Energy
NEE
$183B
$60.6M 0.13%
1,730,492
+98,404
+6% +$3.36M
WEC icon
149
WEC Energy
WEC
$35.7B
$60.4M 0.13%
984,671
+2,652
+0.3% +$164K
BTI icon
150
British American Tobacco
BTI
$131B
$60.3M 0.13%
879,042
+36,515
+4% +$2.54M

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.